One subgroup of APOE ε4/ε4 subjects had unexpectedly low ApoE4 levels, raising questions about potential biological heterogeneity and its impact on Alzheimer’s disease biology. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.